325 related articles for article (PubMed ID: 24917600)
1. Acellular pertussis vaccines and pertussis resurgence: revise or replace?
Ausiello CM; Cassone A
mBio; 2014 Jun; 5(3):e01339-14. PubMed ID: 24917600
[TBL] [Abstract][Full Text] [Related]
2. A novel TLR2 agonist from Bordetella pertussis is a potent adjuvant that promotes protective immunity with an acellular pertussis vaccine.
Dunne A; Mielke LA; Allen AC; Sutton CE; Higgs R; Cunningham CC; Higgins SC; Mills KH
Mucosal Immunol; 2015 May; 8(3):607-17. PubMed ID: 25315966
[TBL] [Abstract][Full Text] [Related]
3. The role of Toll-like receptor-4 in pertussis vaccine-induced immunity.
Banus S; Stenger RM; Gremmer ER; Dormans JA; Mooi FR; Kimman TG; Vandebriel RJ
BMC Immunol; 2008 May; 9():21. PubMed ID: 18498620
[TBL] [Abstract][Full Text] [Related]
4. Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine.
Ross PJ; Sutton CE; Higgins S; Allen AC; Walsh K; Misiak A; Lavelle EC; McLoughlin RM; Mills KH
PLoS Pathog; 2013; 9(4):e1003264. PubMed ID: 23592988
[TBL] [Abstract][Full Text] [Related]
5. Addition of a TLR7 agonist to an acellular pertussis vaccine enhances Th1 and Th17 responses and protective immunity in a mouse model.
Misiak A; Leuzzi R; Allen AC; Galletti B; Baudner BC; D'Oro U; O'Hagan DT; Pizza M; Seubert A; Mills KHG
Vaccine; 2017 Sep; 35(39):5256-5263. PubMed ID: 28823618
[TBL] [Abstract][Full Text] [Related]
6. Immunity to the respiratory pathogen Bordetella pertussis.
Higgs R; Higgins SC; Ross PJ; Mills KH
Mucosal Immunol; 2012 Sep; 5(5):485-500. PubMed ID: 22718262
[TBL] [Abstract][Full Text] [Related]
7. Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination.
Smits K; Pottier G; Smet J; Dirix V; Vermeulen F; De Schutter I; Carollo M; Locht C; Ausiello CM; Mascart F
Vaccine; 2013 Dec; 32(1):111-8. PubMed ID: 24176499
[TBL] [Abstract][Full Text] [Related]
8. Pertussis vaccines and protective immunity.
Kapil P; Merkel TJ
Curr Opin Immunol; 2019 Aug; 59():72-78. PubMed ID: 31078081
[TBL] [Abstract][Full Text] [Related]
9. Lack of evidence supporting a role of IFN-β and TGF-β in differential polarization of Bordetella pertussis specific-T cell responses.
da Silva Antunes R; Quiambao LG; Soldevila F; Sutherland A; Peters B; Sette A
Cytokine; 2021 Jan; 137():155313. PubMed ID: 33002739
[TBL] [Abstract][Full Text] [Related]
10. Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance.
Dorji D; Mooi F; Yantorno O; Deora R; Graham RM; Mukkur TK
Med Microbiol Immunol; 2018 Feb; 207(1):3-26. PubMed ID: 29164393
[TBL] [Abstract][Full Text] [Related]
11. Immunization with whole cell but not acellular pertussis vaccines primes CD4 T
Wilk MM; Borkner L; Misiak A; Curham L; Allen AC; Mills KHG
Emerg Microbes Infect; 2019; 8(1):169-185. PubMed ID: 30866771
[TBL] [Abstract][Full Text] [Related]
12. Pertussis vaccines and the challenge of inducing durable immunity.
Warfel JM; Edwards KM
Curr Opin Immunol; 2015 Aug; 35():48-54. PubMed ID: 26091979
[TBL] [Abstract][Full Text] [Related]
13. Pertussis: Where did we go wrong and what can we do about it?
Locht C
J Infect; 2016 Jul; 72 Suppl():S34-40. PubMed ID: 27161992
[TBL] [Abstract][Full Text] [Related]
14. Differential T- and B-cell responses to pertussis in acellular vaccine-primed versus whole-cell vaccine-primed children 2 years after preschool acellular booster vaccination.
Schure RM; Hendrikx LH; de Rond LG; Oztürk K; Sanders EA; Berbers GA; Buisman AM
Clin Vaccine Immunol; 2013 Sep; 20(9):1388-95. PubMed ID: 23825195
[TBL] [Abstract][Full Text] [Related]
15. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age.
Hendrikx LH; de Rond LG; Oztürk K; Veenhoven RH; Sanders EA; Berbers GA; Buisman AM
Vaccine; 2011 Aug; 29(34):5725-30. PubMed ID: 21669247
[TBL] [Abstract][Full Text] [Related]
16. Th1/Th17 polarization persists following whole-cell pertussis vaccination despite repeated acellular boosters.
da Silva Antunes R; Babor M; Carpenter C; Khalil N; Cortese M; Mentzer AJ; Seumois G; Petro CD; Purcell LA; Vijayanand P; Crotty S; Pulendran B; Peters B; Sette A
J Clin Invest; 2018 Aug; 128(9):3853-3865. PubMed ID: 29920186
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Analysis of Pertussis Vaccine Immunity to Identify Potential Markers of Vaccine-Induced Memory Associated With Whole Cell But Not Acellular Pertussis Immunization in Mice.
Weaver KL; Blackwood CB; Horspool AM; Pyles GM; Sen-Kilic E; Grayson EM; Huckaby AB; Witt WT; DeJong MA; Wolf MA; Damron FH; Barbier M
Front Immunol; 2022; 13():838504. PubMed ID: 35211125
[TBL] [Abstract][Full Text] [Related]
18. Functional Programming of Innate Immune Cells in Response to Bordetella pertussis Infection and Vaccination.
Gillard J; van Schuppen E; Diavatopoulos DA
Adv Exp Med Biol; 2019; 1183():53-80. PubMed ID: 31432398
[TBL] [Abstract][Full Text] [Related]
19. New Pertussis Vaccines: A Need and a Challenge.
Hozbor D
Adv Exp Med Biol; 2019; 1183():115-126. PubMed ID: 31432399
[TBL] [Abstract][Full Text] [Related]
20. Do we need a new vaccine to control the re-emergence of pertussis?
Mills KH; Ross PJ; Allen AC; Wilk MM
Trends Microbiol; 2014 Feb; 22(2):49-52. PubMed ID: 24485284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
